Global Nonsteroidal Antiinflammatory Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Nonsteroidal Antiinflammatory Drugs market report explains the definition, types, applications, major countries, and major players of the Nonsteroidal Antiinflammatory Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi SA

    • Pfizer

    • GlaxoSmithKline PLC

    • DOMESCO

    • Novartis AG

    By Type:

    • Oral

    • Injection

    By End-User:

    • Osteoarthritis

    • Muscle Aches

    • Backaches

    • Dental Pain

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Nonsteroidal Antiinflammatory Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Nonsteroidal Antiinflammatory Drugs Outlook to 2028- Original Forecasts

    • 2.2 Nonsteroidal Antiinflammatory Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Nonsteroidal Antiinflammatory Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Nonsteroidal Antiinflammatory Drugs Market- Recent Developments

    • 6.1 Nonsteroidal Antiinflammatory Drugs Market News and Developments

    • 6.2 Nonsteroidal Antiinflammatory Drugs Market Deals Landscape

    7 Nonsteroidal Antiinflammatory Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Nonsteroidal Antiinflammatory Drugs Key Raw Materials

    • 7.2 Nonsteroidal Antiinflammatory Drugs Price Trend of Key Raw Materials

    • 7.3 Nonsteroidal Antiinflammatory Drugs Key Suppliers of Raw Materials

    • 7.4 Nonsteroidal Antiinflammatory Drugs Market Concentration Rate of Raw Materials

    • 7.5 Nonsteroidal Antiinflammatory Drugs Cost Structure Analysis

      • 7.5.1 Nonsteroidal Antiinflammatory Drugs Raw Materials Analysis

      • 7.5.2 Nonsteroidal Antiinflammatory Drugs Labor Cost Analysis

      • 7.5.3 Nonsteroidal Antiinflammatory Drugs Manufacturing Expenses Analysis

    8 Global Nonsteroidal Antiinflammatory Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Nonsteroidal Antiinflammatory Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Nonsteroidal Antiinflammatory Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Nonsteroidal Antiinflammatory Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injection Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Osteoarthritis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Muscle Aches Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Backaches Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Dental Pain Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Nonsteroidal Antiinflammatory Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.2.2 Canada Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.2 UK Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.3 Spain Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.5 France Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.6 Italy Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.8 Finland Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.9 Norway Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.11 Poland Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.12 Russia Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.2 Japan Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.3 India Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.5.3 Chile Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.5.6 Peru Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.6.3 Oman Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Nonsteroidal Antiinflammatory Drugs Consumption (2017-2022)

    11 Global Nonsteroidal Antiinflammatory Drugs Competitive Analysis

    • 11.1 Sanofi SA

      • 11.1.1 Sanofi SA Company Details

      • 11.1.2 Sanofi SA Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi SA Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

      • 11.1.4 Sanofi SA Nonsteroidal Antiinflammatory Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer

      • 11.2.1 Pfizer Company Details

      • 11.2.2 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

      • 11.2.4 Pfizer Nonsteroidal Antiinflammatory Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GlaxoSmithKline PLC

      • 11.3.1 GlaxoSmithKline PLC Company Details

      • 11.3.2 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

      • 11.3.4 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 DOMESCO

      • 11.4.1 DOMESCO Company Details

      • 11.4.2 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

      • 11.4.4 DOMESCO Nonsteroidal Antiinflammatory Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis AG

      • 11.5.1 Novartis AG Company Details

      • 11.5.2 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

      • 11.5.4 Novartis AG Nonsteroidal Antiinflammatory Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    12 Global Nonsteroidal Antiinflammatory Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Muscle Aches Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Backaches Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Dental Pain Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Nonsteroidal Antiinflammatory Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Nonsteroidal Antiinflammatory Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Nonsteroidal Antiinflammatory Drugs

    • Figure of Nonsteroidal Antiinflammatory Drugs Picture

    • Table Global Nonsteroidal Antiinflammatory Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Nonsteroidal Antiinflammatory Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Global Muscle Aches Consumption and Growth Rate (2017-2022)

    • Figure Global Backaches Consumption and Growth Rate (2017-2022)

    • Figure Global Dental Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Table North America Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Figure United States Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Figure Germany Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Figure China Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Figure Brazil Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Nonsteroidal Antiinflammatory Drugs Consumption by Country (2017-2022)

    • Figure Australia Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Nonsteroidal Antiinflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Table Sanofi SA Company Details

    • Table Sanofi SA Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

    • Table Sanofi SA Nonsteroidal Antiinflammatory Drugs Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

    • Table Pfizer Nonsteroidal Antiinflammatory Drugs Product Portfolio

    • Table GlaxoSmithKline PLC Company Details

    • Table GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

    • Table GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Portfolio

    • Table DOMESCO Company Details

    • Table DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table DOMESCO Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

    • Table DOMESCO Nonsteroidal Antiinflammatory Drugs Product Portfolio

    • Table Novartis AG Company Details

    • Table Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Nonsteroidal Antiinflammatory Drugs Main Business and Markets Served

    • Table Novartis AG Nonsteroidal Antiinflammatory Drugs Product Portfolio

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Muscle Aches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Backaches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dental Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Nonsteroidal Antiinflammatory Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Nonsteroidal Antiinflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.